JDL(SH:688057) Xin Lang Cai Jing·2025-12-21 09:16Core Viewpoint - The company intends to invest 30 million yuan in Beijing Zhongke Hongtai Medical Technology Co., Ltd., acquiring a 10% stake, which has been approved internally and does not constitute a major asset restructuring or related party transaction [1] Group 1: Investment Details - The investment amount is 30 million yuan [1] - After the investment, the company will hold a 10% equity stake in Zhongke Hongtai [1] - The investment has received internal approval from the company [1] Group 2: Company Background - Zhongke Hongtai was founded by Professor Hou Zengguang's team and has strong research capabilities in the field of medical artificial intelligence [1] - The company's products have entered the special review process for innovative medical devices by the National Medical Products Administration [1] Group 3: Financial Performance - As of January to September 2025, Zhongke Hongtai reported revenue of 10.26 thousand yuan and a net loss of 550.77 thousand yuan [1] - The company is currently not profitable, indicating uncertainty in future operating performance and investment returns [1]